Fierce Pharma: Reputation A Top Priority When Picking Prescription Meds

Prescription paper and pills | We. Communications

A Pharma company's reputation Ranked As A Leading Factor in Physician Prescription Decisions, According to We.'s Latest Healthy reputation: More Than Medicine Report

Fierce Pharma, Jacqueline Renfrow, 1 March 2023

In “Healthy Reputation: More Than Medicine,” healthcare professionals displayed their desire for pharma to go beyond just functional characteristics of a medication to address the entire health experience. In an interview with Fierce Pharma, Stephanie Marchesi, President, Global Health shared findings from We.'s latest report. 

“As communicators, our instincts and anecdotal feedback have told us that corporate reputation is important. But now we have hard evidence of its impact, both as influencing prescribing decisions among HCPs as well as contributing to the bottom line for biotech and pharma companies,” explained Marchesi.

To learn more, read We.'s latest Brands in Motion Report "Healthy Reputation: More Than Medicine."

 

   Full Article

 

(Photo courtesy of Fierce Pharma - Getty/LIgorko)

Explore more

Headshot of Sarah Gooding | We. Communications

Future of Communications at PRCA South Africa 2025

Michelle Rose Micor headshot | We. Communications

PRWeek: Pride in PR Featuring Michelle Rose Micor

Abstract blue and pink wave illustration | We. Communications

Reputation Management: Crisis Comms in the Permacrisis Era

Jasmin Athwal and Danile Blank headshots | We. Communications

PRovoke: WE Communications Creates New EMEA Leadership Roles

Abstract colorful illustration of blue and greens | We. Communications

AI Energizes Communicators' Relationship with Work

lllustraion of Big Ben and house of parliment | We. Communications

The Drum: How Comms & Tech Firms Stay Ahead of OSA Changes